Goldman Sachs Lowers Estimates and Price Target On WMS Industries (WMS), Maintains Sell Rating
Get Alerts WMS Hot Sheet
Price: $161.34 +0.64%
Rating Summary:
10 Buy, 12 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
10 Buy, 12 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Goldman Sachs lowered estimates and its price target WMS Industries (NYSE: WMS) following lower guidance from the company after the close Monday.
The analyst lower FY11/FY12/ FY13 EPS estimates to $1.77/$2.00/$2.39 from $1.91/$2.23/$2.55. The firm's price target was cut from $32.50 to $27.
"We remain Sellers of WMS and continue to have a Cautious view on the slot industry. Notably, in today's release, WMS stated that it does not expect meaningful improvements in the industry environment over the remainder of calendar 2011 or for calendar 2012."
For more ratings news on WMS Industries click here and for the rating history of WMS Industries click here.
Shares of WMS Industries closed at $36.22 yesterday.
The analyst lower FY11/FY12/ FY13 EPS estimates to $1.77/$2.00/$2.39 from $1.91/$2.23/$2.55. The firm's price target was cut from $32.50 to $27.
"We remain Sellers of WMS and continue to have a Cautious view on the slot industry. Notably, in today's release, WMS stated that it does not expect meaningful improvements in the industry environment over the remainder of calendar 2011 or for calendar 2012."
For more ratings news on WMS Industries click here and for the rating history of WMS Industries click here.
Shares of WMS Industries closed at $36.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!